Literature DB >> 24704108

Atypical plasma lipid profile in cancer patients: cause or consequence?

Rimsha Munir1, Hina Usman1, Shahida Hasnain1, Karine Smans2, Hubert Kalbacher3, Nousheen Zaidi4.   

Abstract

The aberrant blood lipoprotein levels in cancer patients are reported to be associated with cancer risk and mortality incidents however, there are several discrepancies in the previous reports. Hence the clinical usefulness of plasma/serum levels in risk stratification of a variety of cancers remains elusive. The present review highlights and compiles findings from different research groups regarding association of plasma lipoprotein levels with the risk of developing various types of cancer. We will discuss some prospective underlying mechanisms for this reported association. In addition to that the potential roles of plasma lipids in promoting carcinogenesis will be conferred.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer; Lipoproteins; Plasma lipids; Serum lipids

Mesh:

Substances:

Year:  2014        PMID: 24704108     DOI: 10.1016/j.biochi.2014.03.010

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  11 in total

1.  Metabolomic profiles of current cigarette smokers.

Authors:  Ping-Ching Hsu; Renny S Lan; Theodore M Brasky; Catalin Marian; Amrita K Cheema; Habtom W Ressom; Christopher A Loffredo; Wallace B Pickworth; Peter G Shields
Journal:  Mol Carcinog       Date:  2016-08-22       Impact factor: 4.784

2.  Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer development.

Authors:  Milica Stevanovic; Jelena Vekic; Natasa Bogavac-Stanojevic; Jelena Janac; Zeljka Stjepanovic; Dejan Zeljkovic; Bratislav Trifunovic; Vesna Spasojevic-Kalimanovska; Aleksandra Zeljkovic
Journal:  Biochem Med (Zagreb)       Date:  2018-10-15       Impact factor: 2.313

3.  The Effect of Radiotherapy on the Concentration of Plasma Lipids in Elderly Prostate Cancer Patients.

Authors:  Edyta Wolny-Rokicka; Andrzej Tukiendorf; Jerzy Wydmański; Katarzyna Brzezniakiewicz-Janus; Agnieszka Zembroń-Łacny
Journal:  Am J Mens Health       Date:  2019 Mar-Apr

4.  New diagnostic markers in basal cell carcinoma.

Authors:  Sadaf Anghaei; Kambiz Kamyab-Hesari; Shahriar Haddadi; Maryam Jolehar
Journal:  J Oral Maxillofac Pathol       Date:  2020-05-08

Review 5.  The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges.

Authors:  Vasileios Lazaris; Aikaterini Hatziri; Argiris Symeonidis; Kyriakos E Kypreos
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

6.  Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study.

Authors:  Fan Luo; Kang-Mei Zeng; Jia-Xin Cao; Ting Zhou; Su-Xia Lin; Wen-Juan Ma; Yun-Peng Yang; Zhong-Han Zhang; Fei-Teng Lu; Yan Huang; Hong-Yun Zhao; Li Zhang
Journal:  Lipids Health Dis       Date:  2021-09-20       Impact factor: 3.876

Review 7.  Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?

Authors:  Carmelita Abrahams; Nicholas J Woudberg; Sandrine Lecour
Journal:  Lipids Health Dis       Date:  2022-09-01       Impact factor: 4.315

8.  Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases.

Authors:  Yun Wang; Zhi-Qiang Wang; Feng-Hua Wang; Xue-Fen Lei; Shu-Mei Yan; De-Shen Wang; Fei Zhang; Rui-Hua Xu; Ling-Yun Wang; Yu-Hong Li
Journal:  Oncotarget       Date:  2016-08-30

9.  Hepatocellular carcinoma-associated hypercholesterolemia: involvement of proprotein-convertase-subtilisin-kexin type-9 (PCSK9).

Authors:  Dipti Athavale; Surbhi Chouhan; Vimal Pandey; Shyamananda Singh Mayengbam; Snahlata Singh; Manoj Kumar Bhat
Journal:  Cancer Metab       Date:  2018-10-25

10.  Immunohistochemical Labeling of Low-Density Lipoprotein Receptor and Scavenger Receptor Class B Type 1 Are Increased in Canine Lymphoma.

Authors:  Kristina Ceres; Halle Fitzgerald; Kathryn Shanelle Quiznon; Sean McDonough; Erica Behling-Kelly
Journal:  Front Vet Sci       Date:  2019-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.